Abstract
The potential antitumor effects of jacalin, the plant lectin that specifically recognizes the tumor-associated Thomsen-Friedenreich antigen has been extensively studied. We had earlier reported jacalin to be mitogenic to K562, the Bcr-Abl expressing erythroleukemia cell line. The dearth of studies highlighting the proliferative effects of jacalin and other lectins motivated us to unveil the mechanism underlying the mitogenic effects of jacalin. Caveolin-1 (cav-1) is an integral membrane protein, known to play a crucial role in cell signaling, lipid transport, and membrane trafficking. The role of cav-1 in tumorigenesis is considered to be controversial as it can suppress as well as promote tumor growth, depending on the cellular context. In the present study, we propose that cav-1 plays the central role in the mitogenic effects of jacalin on the K562 cells. In accordance, the mRNA, as well as protein expression of cav-1 was found to be upregulated in the jacalin-treated K562 cells as compared to the untreated control. Further, jacalin stimulation also increased the phosphorylation of ERK and Akt. The rationale that leads to the initial conjecture about cav-1 was that the sequence of jacalin possesses a cav-1-binding site.
Abbreviations
- cav-1:
-
Caveolin-1
References
Sastry, M.V., Banarjee, P., Patanjali, S.R., Swamy, M.J., Swarnalatha, G.V., Surolia, A.: Analysis of saccharide binding to Artocarpus integrifolia lectin reveals specific recognition of T-antigen (beta-D-gal(1----3)D-GalNAc). J. Biol. Chem. 261(25), 11726–11733 (1986)
Kabir, S.: Jacalin: a jackfruit (Artocarpus heterophyllus) seed-derived lectin of versatile applications in immunobiological research. J. Immunol. Methods. 212(2), 193–211 (1998)
Lafont, V., Dornand, J., Covassin, L., Liautard, J.P., Favero, J.: The lectin jacalin triggers CD4-mediated lymphocyte signaling by binding CD4 through a protein-protein interaction. J. Leukoc. Biol. 59(5), 691–696 (1996)
Komath, S.S., Bhanu, K., Maiya, B.G., Swamy, M.J.: Binding of porphyrins by the tumor-specific lectin, Jacalin [Jack fruit (Artocarpus integrifolia) agglutinin]. Biosci. Rep. 20(4), 265–276 (2000). https://doi.org/10.1023/a:1026440907227
Goel, M., Anuradha, P., Kaur, K.J., Maiya, B.G., Swamy, M.J., Salunke, D.M.: Porphyrin binding to jacalin is facilitated by the inherent plasticity of the carbohydrate-binding site: novel mode of lectin–ligand interaction. Acta Crystallogr. Sect. D. 60(2), 281–288 (2004). https://doi.org/10.1107/S0907444903026684
Sahasrabuddhe, A.A., Ahmed, N., Krishnasastry, M.V.: Stress-induced phosphorylation of caveolin-1 and p38, and down-regulation of EGFr and ERK by the dietary lectin jacalin in two human carcinoma cell lines. Cell Stress Chaperones. 11(2), 135–147 (2006)
Geraldino, T.H., Modiano, P., Veronez, L.C., Flória-Santos, M., Garcia, S.B., Pereira-da-Silva, G.: Jacalin has Chemopreventive effects on colon cancer development. Biomed. Res. Int. 4614357(10), 6 (2017)
Lavanya, V., Ahmed, N., Khan, M.K., Jamal, S.: Sustained mitogenic effect on K562 human chronic myelogenous leukemia cells by dietary lectin, jacalin. Glycoconj. J. 33(6), 877–886 (2016)
Yang, H., Guan, L., Li, S., Jiang, Y., Xiong, N., Li, L., Wu, C., Zeng, H., Liu, Y.: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo. Oncotarget. 7(13), 16227 (2016)
Meshulam, T., Simard, J.R., Wharton, J., Hamilton, J.A., Pilch, P.F.: Role of Caveolin-1 and cholesterol in transmembrane fatty acid movement. Biochemistry. 45(9), 2882–2893 (2006). https://doi.org/10.1021/bi051999b
Syme, C.A., Zhang, L., Bisello, A.: Caveolin-1 regulates cellular trafficking and function of the glucagon-like peptide 1 receptor. Mol. Endocrinol. 20(12), 3400–3411 (2006). https://doi.org/10.1210/me.2006-0178
Williams, T.M., Lisanti, M.P.: The caveolin proteins. Genome Biol. 5(3), 214–214 (2004). https://doi.org/10.1186/gb-2004-5-3-214
Parolini, I., Sargiacomo, M., Galbiati, F., Rizzo, G., Grignani, F., Engelman, J.A., Okamoto, T., Ikezu, T., Scherer, P.E., Mora, R., Rodriguez-Boulan, E., Peschle, C., Lisanti, M.P.: Expression of caveolin-1 is required for the transport of caveolin-2 to the plasma membrane. Retention of caveolin-2 at the level of the golgi complex. J. Biol. Chem. 274(36), 25718–25725 (1999)
Song, K.S., Scherer, P.E., Tang, Z., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D.S., Lisanti, M.P.: Expression of Caveolin-3 in skeletal, cardiac, and smooth muscle cells: CAVEOLIN-3 IS a COMPONENT OF THE SARCOLEMMA AND CO-FRACTIONATES WITH DYSTROPHIN AND DYSTROPHIN-ASSOCIATED GLYCOPROTEINS*. J. Biol. Chem. 271(25), 15160–15165 (1996). https://doi.org/10.1074/jbc.271.25.15160
Fra, A.M., Williamson, E., Simons, K., Parton, R.G.: De novo formation of caveolae in lymphocytes by expression of VIP21-caveolin. Proc. Natl. Acad. Sci. U. S. A. 92(19), 8655–8659 (1995)
Parton, R.G., Hanzal-Bayer, M., Hancock, J.F.: Biogenesis of caveolae: a structural model for caveolin-induced domain formation. J. Cell Sci. 119(Pt 5), 787–796 (2006)
Wiechen, K., Diatchenko, L., Agoulnik, A., Scharff, K.M., Schober, H., Arlt, K., Zhumabayeva, B., Siebert, P.D., Dietel, M., Schäfer, R., Sers, C.: Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159(5), 1635–1643 (2001). https://doi.org/10.1016/s0002-9440(10)63010-6
Huertas-Martínez, J., Rello-Varona, S., Herrero-Martín, D., Barrau, I., García-Monclús, S., Sáinz-Jaspeado, M., Lagares-Tena, L., Núñez-Álvarez, Y., Mateo-Lozano, S., Mora, J., Roma, J., Toran, N., Moran, S., López-Alemany, R., Gallego, S., Esteller, M., Peinado, M.A., Del Muro, X.G., Tirado, O.M.: Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth. Oncotarget. 5(20), 9744–9755 (2014). https://doi.org/10.18632/oncotarget.2403
Tirado, O.M., MacCarthy, C.M., Fatima, N., Villar, J., Mateo-Lozano, S., Notario, V.: Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation. Int. J. Cancer. 126(2), 426–436 (2010). https://doi.org/10.1002/ijc.24754
Yuan, G., Regel, I., Lian, F., Friedrich, T., Hitkova, I., Hofheinz, R.D., Ströbel, P., Langer, R., Keller, G., Röcken, C., Zimmermann, W., Schmid, R.M., Ebert, M.P.A., Burgermeister, E.: WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells. Oncogene. 32(3), 375–387 (2013). https://doi.org/10.1038/onc.2012.40
Wang, Z., Wang, N., Liu, P., Peng, F., Tang, H., Chen, Q., Xu, R., Dai, Y., Lin, Y., Xie, X., Peng, C., Situ, H.: Caveolin-1, a stress-related oncotarget, in drug resistance. Oncotarget. 6(35), 37135–37150 (2015)
Ting Tse, E.Y., Fat Ko, F.C., Kwan Tung, E.K., Chan, L.K., Wah Lee, T.K., Wai Ngan, E.S., Man, K., Tsai Wong, A.S., Ng, I.O.-L., Ping Yam, J.W.: Caveolin-1 overexpression is associated with hepatocellular carcinoma tumourigenesis and metastasis. J. Pathol. 226(4), 645–653 (2012). https://doi.org/10.1002/path.3957
Basu Roy, U.K., Henkhaus, R.S., Loupakis, F., Cremolini, C., Gerner, E.W., Ignatenko, N.A.: Caveolin-1 is a novel regulator of K-RAS-dependent migration in colon carcinogenesis. Int. J. Cancer. 133(1), 43–57 (2013). https://doi.org/10.1002/ijc.28001
Shimizu, K., Kirita, K., Aokage, K., Kojima, M., Hishida, T., Kuwata, T., Fujii, S., Ochiai, A., Funai, K., Yoshida, J., Tsuboi, M., Ishii, G.: Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma. J. Cancer Res. Clin. Oncol. 143(2), 321–328 (2017)
Liu, W.R., Jin, L., Tian, M.X., Jiang, X.F., Yang, L.X., Ding, Z.B., Shen, Y.H., Peng, Y.F., Gao, D.M., Zhou, J., Qiu, S.J., Dai, Z., Fan, J., Shi, Y.H.: Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 40(2), 169–178 (2016)
Ruan, H., Li, X., Yang, H., Song, Z., Tong, J., Cao, Q., Wang, K., Xiao, W., Xiao, H., Chen, X., Xu, G., Bao, L., Xiong, Z., Yuan, C., Liu, L., Qu, Y., Hu, W., Gao, Y., Ru, Z., Chen, K., Zhang, X.: Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma. Exp. Cell Res. 358(2), 269–278 (2017)
Glenney Jr., J.R., Soppet, D.: Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. U. S. A. 89(21), 10517–10521 (1992)
Boscher, C., Nabi, I.R.: Caveolin-1: role in cell signaling. Adv. Exp. Med. Biol. 729, 29–50 (2012)
Fridolfsson, H.N., Roth, D.M., Insel, P.A., Patel, H.H.: Regulation of intracellular signaling and function by caveolin. FASEB J. 28(9), 3823–3831 (2014). https://doi.org/10.1096/fj.14-252320
Qin, L.J., Jia, Y.S., Zhang, Y.B., Wang, Y.H.: Interleukin-1β induces the upregulation of caveolin-1 expression in a rat brain tumor model. Biomed Rep. 4(4), 433–436 (2016)
Bae, G.D., Park, E.-Y., Kim, K., Jang, S.-E., Jun, H.-S., Oh, Y.S.: Upregulation of caveolin-1 and its colocalization with cytokine receptors contributes to beta cell apoptosis. Sci. Rep. 9(1), 16785 (2019). https://doi.org/10.1038/s41598-019-53278-z
Faheina-Martins, G.V., da Silveira, A.L., Ramos, M.V., Marques-Santos, L.F., Araujo, D.A.: Influence of fetal bovine serum on cytotoxic and genotoxic effects of lectins in MCF-7 cells. J. Biochem. Mol. Toxicol. 25(5), 290–296 (2011)
Fra, A.M., Williamson, E., Simons, K., Parton, R.G.: Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J. Biol. Chem. 269(49), 30745–30748 (1994)
Sager, R., Sheng, S., Anisowicz, A., Sotiropoulou, G., Zou, Z., Stenman, G., Swisshelm, K., Chen, Z., Hendrix, M.J., Pemberton, P., et al.: RNA genetics of breast cancer: maspin as paradigm. Cold Spring Harb. Symp. Quant. Biol. 59, 537–546 (1994)
Ma, W., Wang, D.D., Li, L., Feng, Y.K., Gu, H.M., Zhu, G.M., Piao, J.H., Yang, Y., Gao, X., Zhang, P.X.: Caveolin-1 plays a key role in the oleanolic acid-induced apoptosis of HL-60 cells. Oncol. Rep. 32(1), 293–301 (2014)
Li, L., Ren, C.H., Tahir, S.A., Ren, C., Thompson, T.C.: Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. Mol. Cell. Biol. 23(24), 9389–9404 (2003)
Hehlgans, S., Eke, I., Storch, K., Haase, M., Baretton, G.B., Cordes, N.: Caveolin-1 mediated radioresistance of 3D grown pancreatic cancer cells. Radiother. Oncol. 92(3), 362–370 (2009). https://doi.org/10.1016/j.radonc.2009.07.004
Henkhaus, R.S., Roy, U.K., Cavallo-Medved, D., Sloane, B.F., Gerner, E.W., Ignatenko, N.A.: Caveolin-1-mediated expression and secretion of kallikrein 6 in colon cancer cells. Neoplasia. 10(2), 140–148 (2008)
Vetterkind, S., Poythress, R.H., Lin, Q.Q., Morgan, K.G.: Hierarchical scaffolding of an ERK1/2 activation pathway. Cell Commun Signal. 11(1), 65 (2013). https://doi.org/10.1186/1478-811x-11-65
Arpaia, E., Blaser, H., Quintela-Fandino, M., Duncan, G., Leong, H.S., Ablack, A., Nambiar, S.C., Lind, E.F., Silvester, J., Fleming, C.K., Rufini, A., Tusche, M.W., Brüstle, A., Ohashi, P.S., Lewis, J.D., Mak, T.W.: The interaction between caveolin-1 and rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk. Oncogene. 31(7), 884–896 (2012)
Song, G., Ouyang, G., Bao, S.: The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9(1), 59–71 (2005)
Vincent, E.E., Elder, D.J., Thomas, E.C., Phillips, L., Morgan, C., Pawade, J., Sohail, M., May, M.T., Hetzel, M.R., Tavaré, J.M.: Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br. J. Cancer. 104(11), 1755–1761 (2011)
Seshacharyulu, P., Pandey, P., Datta, K., Batra, S.K.: Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. Cancer Lett. 335(1), 9–18 (2013)
Yamada, T., Katagiri, H., Asano, T., Inukai, K., Tsuru, M., Kodama, T., Kikuchi, M., Oka, Y.: 3-phosphoinositide-dependent protein kinase 1, an Akt1 kinase, is involved in dephosphorylation of Thr-308 of Akt1 in Chinese hamster ovary cells. J. Biol. Chem. 276(7), 5339–5345 (2001)
Kuo, Y.C., Huang, K.Y., Yang, C.H., Yang, Y.S., Lee, W.Y., Chiang, C.W.: Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J. Biol. Chem. 283(4), 1882–1892 (2008)
Couet, J., Sargiacomo, M., Lisanti, M.P.: Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272(48), 30429–30438 (1997)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
V, L., Jamal, S. & Ahmed, N. Increased ERK phosphorylation and caveolin-1 expression on K562 human chronic myelogenous leukemia cells by jacalin, a dietary plant lectin. Glycoconj J 38, 361–368 (2021). https://doi.org/10.1007/s10719-021-09998-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10719-021-09998-4